|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/501 | (2006.01) |
| A61K 31/506 | (2006.01) | ||
| A61K 31/55 | (2006.01) | ||
| A61P 25/26 | (2006.01) | ||
| A61K 31/4545 | (2006.01) | ||
| A61P 43/00 | (2006.01) |
| (11) | Number of the document | 2945633 |
| (13) | Kind of document | T |
| (96) | European patent application number | 14703426.8 |
| Date of filing the European patent application | 2014-01-13 | |
| (97) | Date of publication of the European application | 2015-11-25 |
| (45) | Date of publication and mention of the grant of the patent | 2021-06-30 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/IB2014/058225 |
| Date | 2014-01-13 |
| (87) | Number | WO 2014/111838 |
| Date | 2014-07-24 |
| (30) | Number | Date | Country code |
| 201361752772 P | 2013-01-15 | US |
| (72) |
FENDT, Markus , CH
FEUERBACH, Dominik , CH
FINNEMA, Sjoerd Johannes , SE
HALLDIN, Christer , SE
JOHNS, Donald , US
LOPEZ-LOPEZ, Cristina , CH
MCALLISTER, Kevin Hall , CH
SOVAGO, Judit , CH
WEISS, Markus , CH
|
| (73) |
Novartis AG ,
Lichtstrasse 35, 4056 Basel,
CH
|
| (54) | USE OF ALPHA 7 NICOTINIC ACETYLCHOLINE RECEPTOR AGONISTS |
| USE OF ALPHA 7 NICOTINIC ACETYLCHOLINE RECEPTOR AGONISTS |